Suvretta Capital Management, LLC Intra Cellular Therapies, Inc. Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

A detailed history of Suvretta Capital Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 1,439,026 shares of ITCI stock, worth $120 Million. This represents 4.14% of its overall portfolio holdings.

Number of Shares
1,439,026
Previous 1,565,996 8.11%
Holding current value
$120 Million
Previous $107 Million 1.9%
% of portfolio
4.14%
Previous 4.48%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$67.99 - $80.84 $8.63 Million - $10.3 Million
-126,970 Reduced 8.11%
1,439,026 $105 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $39.3 Million - $48.4 Million
606,798 Added 63.26%
1,565,996 $107 Million
Q1 2024

May 15, 2024
SELL
$64.37 - $75.65 $13.3 Million - $15.6 Million
-206,750 Reduced 17.73%
959,198 $66.4 Million
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $9.45 Million - $15 Million
-203,901 Reduced 14.88%
1,165,948 $83.5 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $8.9 Million - $11 Million
170,878 Added 14.25%
1,369,849 $71.4 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $7.1 Million - $9.23 Million
162,023 Added 15.62%
1,198,971 $64.9 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $8.15 Million - $10.1 Million
184,990 Added 21.71%
1,036,948 $54.9 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $20.8 Million - $29.2 Million
-486,742 Reduced 36.36%
851,958 $39.6 Million
Q2 2022

Aug 15, 2022
SELL
$43.0 - $65.64 $8.31 Million - $12.7 Million
-193,223 Reduced 12.61%
1,338,700 $76.4 Million
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $10.8 Million - $17.4 Million
279,977 Added 22.36%
1,531,923 $93.7 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $6.12 Million - $9.06 Million
213,176 Added 20.52%
1,251,946 $46.7 Million
Q1 2021

May 17, 2021
BUY
$30.8 - $39.51 $4.09 Million - $5.25 Million
132,800 Added 14.66%
1,038,770 $35.2 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $9.66 Million - $13.3 Million
413,700 Added 84.04%
905,970 $28.8 Million
Q3 2020

Nov 16, 2020
BUY
$17.61 - $31.86 $8.67 Million - $15.7 Million
492,270 New
492,270 $12.6 Million

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.88B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email